Clinical Trials Sponsored by Lambda Therapeutic Research Ltd.

Total 33 results

Intas Pharmaceuticals, Ltd.
Lambda Therapeutic Research Ltd.

Completed

Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers

India
Intas Pharmaceuticals, Ltd.
Lambda Therapeutic Research Ltd.

Completed

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Healthy Volunteers | Immunogenicity

India
Ayana Pharma Ltd.,
Lambda Therapeutic Research Ltd.

Completed

A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.

Ovarian Cancer Recurrent

India
Unilever R&D
Lambda Therapeutic Research Ltd.

Completed

Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response

Blood Glucose

India
Unilever R&D
Lambda Therapeutic Research Ltd.

Completed

Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose

Blood Glucose

India
Jina Pharmaceuticals Inc.
Lambda Therapeutic Research Ltd.; Intas Pharmaceuticals, Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer

United States, India
Lambda Therapeutic Research Ltd.
Intas Pharmaceutical Limited (Biopharma Division)

Recruiting

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

India
Jina Pharmaceuticals Inc.
Novum Pharmaceutical Research Services; Lambda Therapeutic Research Ltd.; Intas...

Recruiting

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Bipolar I Disorder

United States
Vidara Therapeutics Research Ltd

Unknown

Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers (FLS)

Adverse Effects in the Therapeutic Use of Interferon

United States
Atopix Therapeutics, Ltd.
Simbec Research

Completed

First in Man Evaluation of Single and Multiple Doses of Oral ATX2417

Allergy

United Kingdom
Atopix Therapeutics, Ltd.
Simbec Research

Completed

Evaluation of Metabolic Profile of OC000459

Asthma

United Kingdom
Arana Therapeutics Ltd
Trident Clinical Research Pty Ltd

Completed

Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Rheumatoid Arthritis

Sri Lanka
Atlantic Therapeutics
Bio-Medical Research, Ltd.

Completed

Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US

Stress Urinary Incontinence

United States
Raziel Therapeutics Ltd.
Spaulding Clinical Research LLC

Completed

Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers

Obesity | Weight Loss | Overweight and Obesity

United States
OcuCure Therapeutics, Inc.
Semler Research Center Pvt. Ltd.

Terminated

A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

Proliferative Diabetic Retinopathy (PDR)

Bangladesh
F-star Therapeutics, Inc.
CSI Medical Research Pte Ltd

Terminated

Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients

Hepatitis B | Hepatitis B, Chronic | HBV

Singapore
Imperial College London
Medical Research Council; Atopix Therapeutics, Ltd.

Completed

Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

Picornaviridae Infections | Asthma | Common Cold | Rhinovirus

United Kingdom
ACEA Therapeutics, Inc.
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Unknown

Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
Enlivex Therapeutics Ltd.
Cato Research; Accelsiors CRO & Consultancy Services

Active, not recruiting

A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

Sepsis | Intraabdominal Infections | Cholecystitis, Acute | Urinary Tract Infections | Community-acquired Pneumonia | Cholangitis Acute

Netherlands, Israel, France, Belgium, Spain
Children's Hospital of Philadelphia
Friedreich's Ataxia Research Alliance; Vidara Therapeutics Research Ltd

Completed

Interferon Gamma-1b in Friedreich Ataxia (FRDA)

Friedreich Ataxia

United States
Vidac Pharma
PharPoint Research, Inc.; Therapeutics, Inc.; Medistat Ltd., Israel

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b)

Actinic Keratosis

United States
Galera Therapeutics, Inc.
INC Research Australia Pty Ltd; Nucleous Network

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers

Healthy Volunteer

Australia
Abide Therapeutics
CogState Ltd.; FGK Clinical Research GmbH; BASi (Bioanalytical Systems, Inc.)

Completed

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Tourette Syndrome | Motor Tic Disorder

Germany, Poland, Spain
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
PATH
University College, London; FHI 360; Medical Research Council Unit, The Gambia; Serum Institute of India Pvt. Ltd...

Completed

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Pneumonia, Pneumococcal

Gambia
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
Michael Peluso, MD
Aerium Therapeutics; Patient-Led Research Collaborative; PolyBio Research Foundation

Active, not recruiting

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (outSMART-LC)

Long COVID | Post-Acute COVID-19 | Post-Acute Sequela of COVID-19

United States
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Invex Therapeutics Ltd.
Premier Research Group plc; University Hospitals Birmingham Neuro Ophthalmology... and other collaborators

Terminated

A Trial to Determine the Efficacy and Safety of Presendin in IIH (IIH EVOLVE)

Idiopathic Intracranial Hypertension

Israel, Germany, Australia, United States, United Kingdom, New Zealand
Canadian Cancer Trials Group
Canadian Cancer Society (CCS); ATGen Canada Inc; Ontario Institute for Cancer... and other collaborators

Active, not recruiting

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO)

Covid-19 | Cancer

Canada
University of Virginia
University of Michigan; International Centre for Diarrhoeal Disease Research... and other collaborators

Recruiting

Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy (SBT4EE)

Intestinal Permeability | Enteropathy | Malnutrition, Child | Glucose-Galactose Malabsorption | Linear Growth Failure

Australia, Bangladesh, India, Jamaica, Kenya, Peru, United Kingdom, Zambia
Imperial College London
London School of Hygiene and Tropical Medicine; Erasmus Medical Center; University... and other collaborators

Completed

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM) (PERFORM)

Inflammation | Fever | Infection

United Kingdom

Clinical Trials Sponsored by Lambda Therapeutic Research Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations